Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2014

01-11-2014 | Original Article

Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome

Authors: Liping Sun, Yanjie Hu, Aime Niyonsaba, Qiaoxia Tong, Li Lu, Huiyu Li, Shenghua Jie

Published in: Clinical and Experimental Medicine | Issue 4/2014

Login to get access

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by SFTS virus (SFTSV) with a high fatality rate. But the immunofunction was still unclear. The objective of our study was to assess the immunofunction in SFTS patients. Immunofunction test with flow cytometry which contains CD3+, CD4+ and CD8+ T lymphocytes, B cells and NK cells would be used for detecting serum samples collected from 34 SFTS cases and 20 healthy donors. We found that CD3+ and CD4+ T lymphocytes were significantly diminished in SFTS compared to normal control. In contrast, the percentage of NK cells was elevated. Further analysis revealed that the number of CD3+ and CD4+ T lymphocytes showed that there was a more robust pattern of depression in acute phase and severe SFTS infection compared to the patients in recovery phase and mild SFTS infection. But NK cells were significantly increased in acute phase and severe SFTS. They reverted to the near normal levels in convalescent phase. Additionally, the levels of CD3+ and CD4+ T lymphocytes progressively decreased in death group when compared with the survival group, but the level of B cells was higher. The damages of immune system were obvious, and the immune dysfunction might be partly responsible for disease progression of patients with SFTSV infection.
Literature
2.
go back to reference Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK et al (2011) A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 53:1208–1214. doi:10.1093/cid/cir732 PubMedCrossRef Bao CJ, Guo XL, Qi X, Hu JL, Zhou MH, Varma JK et al (2011) A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 53:1208–1214. doi:10.​1093/​cid/​cir732 PubMedCrossRef
5.
go back to reference Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J (2010) Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41:61PubMedCrossRefPubMedCentral Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J (2010) Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41:61PubMedCrossRefPubMedCentral
10.
go back to reference Zhang YZ, He YW, Dai YA, Xiong Y, Zheng H, Zhou DJ et al (2012) Hemorrhagic fever caused by a novel bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis 54:527–533. doi:10.1093/cid/cir804 PubMedCrossRef Zhang YZ, He YW, Dai YA, Xiong Y, Zheng H, Zhou DJ et al (2012) Hemorrhagic fever caused by a novel bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis 54:527–533. doi:10.​1093/​cid/​cir804 PubMedCrossRef
11.
go back to reference Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, 430 mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 431:17264–17269CrossRef Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, 430 mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 431:17264–17269CrossRef
12.
go back to reference Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG (2007) Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol 81:2554–2563PubMedCrossRefPubMedCentral Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG (2007) Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol 81:2554–2563PubMedCrossRefPubMedCentral
14.
go back to reference Jie SH, Zhou Y, Sun LP, Liang KW, Yi XL, Li HY (2013) Close correlation between development of MODS during the initial 72 h of hospitalization and hospital mortality in severe fever with thrombocytopenia syndrome. J Huazhong Univ Sci Technol 33:81–85. doi:10.1007/s11596-013-1075-1 CrossRef Jie SH, Zhou Y, Sun LP, Liang KW, Yi XL, Li HY (2013) Close correlation between development of MODS during the initial 72 h of hospitalization and hospital mortality in severe fever with thrombocytopenia syndrome. J Huazhong Univ Sci Technol 33:81–85. doi:10.​1007/​s11596-013-1075-1 CrossRef
15.
go back to reference Lee SH, Miyagi T, Biron CA (2007) Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 28:252–259PubMedCrossRef Lee SH, Miyagi T, Biron CA (2007) Keeping NK cells in highly regulated antiviral warfare. Trends Immunol 28:252–259PubMedCrossRef
16.
go back to reference Maghazachi AA, Al-Aoukaty A (1998) Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J 12:913–924PubMed Maghazachi AA, Al-Aoukaty A (1998) Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J 12:913–924PubMed
17.
go back to reference Li T, Qiu Z, Han Y, Wang Z, Fan H, Lu W, et al (2003). Rapid loss of both CD4 + and CD8 + T lymphocyte subsets during the acute phase of severe acute respiratory syndrome. Chin Med J (Engl)116:985-987. PMID:12890367 Li T, Qiu Z, Han Y, Wang Z, Fan H, Lu W, et al (2003). Rapid loss of both CD4 + and CD8 + T lymphocyte subsets during the acute phase of severe acute respiratory syndrome. Chin Med J (Engl)116:985-987. PMID:12890367
18.
go back to reference Gao Y, Wang Y, He JR, Miu Q (2002) Study on subtype of T-lymphocyte in the critical cases with severe pneumonia. Ningxia Med J 24:331–332 Gao Y, Wang Y, He JR, Miu Q (2002) Study on subtype of T-lymphocyte in the critical cases with severe pneumonia. Ningxia Med J 24:331–332
21.
go back to reference Maghazachi AA (2010) Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 341:37–58 (PMID:11818437)PubMed Maghazachi AA (2010) Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 341:37–58 (PMID:11818437)PubMed
22.
go back to reference Sobek V, Balkow S, Körner H, Simon MM (2002) Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Eur J Immunol 32:2490–2499 (PMID:12207333)PubMedCrossRef Sobek V, Balkow S, Körner H, Simon MM (2002) Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Eur J Immunol 32:2490–2499 (PMID:12207333)PubMedCrossRef
Metadata
Title
Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome
Authors
Liping Sun
Yanjie Hu
Aime Niyonsaba
Qiaoxia Tong
Li Lu
Huiyu Li
Shenghua Jie
Publication date
01-11-2014
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 4/2014
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-013-0259-0

Other articles of this Issue 4/2014

Clinical and Experimental Medicine 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.